Susan G. Komen adds 16 Breast Cancer research leaders

Susan G. Komen, the world’s largest nonprofit breast cancer organization, welcomes 16 new leaders in breast cancer research and advocacy to their Komen Scholars international advisory group. Komen Scholars help guide breast cancer research and scientific programs, education, and advocacy work, as well as public health efforts in the U.S. and abroad. The Komen Scholars include the brightest, most creative, and most hardworking individuals in the field today.    The new members are:

• From the University of Texas MD Anderson Cancer Center, Abenaa M. Brewster, M.D., MHS (Risk Reduction, Survivorship, Disparities);
• From the Cancer Research UK Cambridge Research Institute, Jason S. Carroll, Ph.D. (Biology, Endocrine Resistance);
• From the Columbia University Medical Center, Dawn L. Hershman, M.D., M.S. Center (Survivorship, Health Outcomes, Disparities);
• From Princeton University, Yibin Kang, Ph.D. (Biology, Metastasis);
• From the Dana-Farber Cancer Institute, Tari A. King, M.D. (Clinical Research, Treatment);
• From the Mayo Clinic, Keith L. Knutson, Ph.D. (Biology, Immunotherapy);
• From the Vanderbilt-Ingram Cancer Center, Mia A. Levy, M.D., Ph.D. (Big Data, Precision Medicine);
• From the Dana-Farber Cancer Institute, Jennifer A. Ligibel, M.D. (Treatment, Lifestyle Interventions);
• From the University of California, San Francisco (UCSF), Anna M. Napoles, Ph.D., MPH (Survivorship, Disparities);
• From the Henry Ford Health System, Lisa A. Newman, M.D., MPH (Risk Reduction, Disparities, Global Health);
• From the University of Pittsburgh, Steffi Oesterreich, Ph.D. (Biology, Endocrine Resistance);
• From the University of North Carolina, Charles M. Perou, Ph.D. (Genomics, Precision Medicine);
• From the Dana-Farber Cancer Institute, Kornelia Polyak, M.D., Ph.D. (Biology, Tumor Diversity, Risk, Prevention);
• From Yale University, Lajos Pusztai, M.D., D. Phil. (Clinical Research, Treatment, Big Data);
• From the Mayo Clinic, Deborah J. Rhodes, M.D. (Early Detection, Imaging, Breast Density);
• From the Huntsman Cancer Institute, Alana L. Welm, Ph.D. (Biology, Metastasis).